NEW YORK (Reuters Health) Oct 11 –
After hearing the options, the overwhelming majority of women with early stage breast carcinoma choose breast-conserving therapy (BCT).
That’s according to results of a study of 578 consecutive women with ductal carcinoma in situ or clinical Stage I or II breast carcinoma who were eligible for BCT, mastectomy alone, or mastectomy with immediate reconstruction.
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!